R Bassan, T Lerede, M Buelli, G Borleri, P Bellavita, A Rambaldi, T Barbui. A new combination of carboplatin, high-dose cytarabine and cross-over mitoxantrone or idarubicin for refractory and relapsed acute myeloid leukemia. haematol [Internet]. 1998May1 [cited 2024Nov.23];83(5):422-7. Available from: https://haematologica.org/article/view/1107